Structure--activity relationship of inhibitors of hydroxyapatite formation
- PMID: 534518
- PMCID: PMC1161691
- DOI: 10.1042/bj1840181
Structure--activity relationship of inhibitors of hydroxyapatite formation
Abstract
The relative abilities of some compounds to inhibit the transformation of amorphous calcium phosphate into hydroxyapatite were determined. Organic diphosphates, fructose 1,6-bisphosphate, pyrophosphate, imidodiphosphate and 3-phospholycerate all inhibited to various degrees. Strong inhibition was observed with phosphonoformate, and phosphocitrate proved to be the most powerful of the inhibitors examined. On the basis of these new findings an improved concept of the structure--activity relationship of inhibitors is proposed and mechanisms for inhibitor action are discussed.
Similar articles
-
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.Calcif Tissue Int. 1982 Mar;34(2):169-77. doi: 10.1007/BF02411229. Calcif Tissue Int. 1982. PMID: 6282411
-
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.Arch Virol. 1980;66(3):261-4. doi: 10.1007/BF01314739. Arch Virol. 1980. PMID: 6449917
-
Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.Antimicrob Agents Chemother. 1978 Feb;13(2):188-92. doi: 10.1128/AAC.13.2.188. Antimicrob Agents Chemother. 1978. PMID: 206200 Free PMC article.
-
Trisodium phosphonoformate, a new antiviral compound.Science. 1978 Sep 1;201(4358):819-21. doi: 10.1126/science.210500. Science. 1978. PMID: 210500
-
Experimental studies on the antiherpetic agent phosphonoformic acid.Adv Ophthalmol. 1979;38:276-80. Adv Ophthalmol. 1979. PMID: 230720 No abstract available.
Cited by
-
Inhibition of the amorphous calcium phosphate phase transformation reaction by polyphosphates and metal ions.Calcif Tissue Int. 1990 Aug;47(2):112-6. doi: 10.1007/BF02555994. Calcif Tissue Int. 1990. PMID: 2167763
-
Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis.BMC Musculoskelet Disord. 2015 Sep 30;16:270. doi: 10.1186/s12891-015-0724-x. BMC Musculoskelet Disord. 2015. PMID: 26424660 Free PMC article.
-
Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite.Calcif Tissue Int. 1991 Aug;49(2):134-7. doi: 10.1007/BF02565136. Calcif Tissue Int. 1991. PMID: 1655175
-
Inhibition of calcium phosphate precipitation by human salivary acidic proline-rich proteins: structure-activity relationships.Calcif Tissue Int. 1987 Mar;40(3):126-32. doi: 10.1007/BF02555696. Calcif Tissue Int. 1987. PMID: 3105842
-
Biological activities of phosphocitrate: a potential meniscal protective agent.Biomed Res Int. 2013;2013:726581. doi: 10.1155/2013/726581. Epub 2013 Jul 11. Biomed Res Int. 2013. PMID: 23936839 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources